Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia

European Psychiatry

Volumn 27, Issue 6, 2012, Pages 401-405

  Karow, A ^a   Moritz, S ^a   Lambert, M ^a   Schottle D ^a   Naber, D ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Functional outcome; Recovery; Remission; Schizophrenia; Subjective well being

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISORIENTATION; DSM-IV; EMOTIONAL STRESS; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; OBSERVATIONAL STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; SCHIZOPHRENIA; SELF CARE; SELF CONTROL; SOCIAL ATTITUDE; SYMPTOM;

ACTIVITIES OF DAILY LIVING; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF CARE;

EID: 84863872151     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.01.012     Document Type: Article

References (26)

1. Andreasen N.C., Carpenter W.T., Kane J.M., et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449.
2. APA Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington DC. 4th ed.
3. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Res 1994, 52:295-303.
4. Bobes J., Ciudad A., Alvarez E., et al. Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission. Schizophrenia Res 2009, 115:58-66.
5. Boden R., Sundstrom J., Lindstrom E., Lindstrom L. Association between symptomatic remission and functional outcome in first-episode schizophrenia. Schizophrenia Res 2009, 107:232-237.
6. Cohen C.I., Pathak R., Ramirez P.M., Vahia I. Outcome among community dwelling older adults with schizophrenia: results using five conceptual models. Community Ment Health J 2009, 45:151-156.
7. DeHaan L., Weisfelt M., Dingemans P.M., et al. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology 2002, 162:24-28.
8. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the " right stuff" ?. Schizophr Bull 2000, 26:119-136.
9. Hafner H. Schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 2005, 255:157-158.
10. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr Res 2007, 93:160-168.
11. Karow A., Czekalla J., Dittmann R.W., et al. Association of subjective well-being, symptoms, and side effects with compliance after 12months of treatment in schizophrenia. J Clin Psychiatry 2007, 68:75-80.
12. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
13. Lambert M., De Marinis T., Pfeil J., Naber D., Schreiner A. Establishing remission and good clinical functioning in schizophrenia: Predictors of best outcome with long-term risperidone long-acting injectable treatment. Eur Psychiatry 2009.
14. Lambert M., Naber D., Schacht A., et al. Rates and predictors of remission and recovery during 3years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand 2008, 118:220-229.
15. Lambert M., Schimmelmann B.G., Karow A., Naber D. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance. Pharmacopsychiatry 2003, 36(Suppl3):S181-S190.
16. Lambert M., Schimmelmann B.G., Naber D., et al. Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride. Pharmacopsychiatry 2009, 42:277-283.
17. Lambert M., Schimmelmann B.G., Naber D., et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 2006, 67:1690-1697.
18. Leucht S., Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006, 39:161-170.
19. Llorca P.M., Lancon C., Lancrenon S., et al. The " Functional Remission of General Schizophrenia" (FROGS) scale: development and validation of a new questionnaire. Schizophr Res 2009, 113:218-225.
20. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995, 10(Suppl 3):133-138.
21. Naber D., Moritz S., Lambert M., et al. Improvement of schizophrenic patients; subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001, 50(1-2):79-88.
22. Schennach-Wolff R., Jager M., Seemuller F., et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res 2009, 113:210-217.
23. van der Gaag M., Cuijpers A., Hoffman T., et al. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr Res 2006, 85:273-279.
24. van Os J., Burns T., Cavallaro R., et al. Standardized remission criteria in schizophrenia. Acta Psychiatr Scand 2006, 113:91-95.
25. Warner R. Recovery from schizophrenia and the recovery model. Curr Opin Psychiatry 2009, 22:374-380.
26. Wunderink L., Nienhuis F.J., Sytema S., Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull 2007, 33:792-796.